1 / 45

Glucose homeostasis, pathophysiology of diabetes & ADA Guidelines

Glucose homeostasis, pathophysiology of diabetes & ADA Guidelines. JC Lynch PHPT 726 2007. Glucose homeostasis. Glycogenolysis Catabolism of glycogen. Gluconeogenesis Production of glucose from carbohydrates or proteins. Glycogenolysis & Glucoeogenesis Hepatic Glucose Output.

laura-bass
Télécharger la présentation

Glucose homeostasis, pathophysiology of diabetes & ADA Guidelines

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Glucose homeostasis, pathophysiology of diabetes & ADA Guidelines JC Lynch PHPT 726 2007

  2. Glucose homeostasis

  3. Glycogenolysis Catabolism of glycogen. Gluconeogenesis Production of glucose from carbohydrates or proteins. Glycogenolysis & GlucoeogenesisHepatic Glucose Output

  4. (this is the simple slide: know this first)

  5. Comparison of normal glucose patterns to patient with diabetes (probably type 1).

  6. Direct Effects of Insulin • Glucose metabolism • Lipoprotein metabolism • Ketone metabolism • Protein metabolism

  7. Insulin Action: Definitions Insulin Sensitivity • Ability of insulin to lower circulating glucose concentrations • Insulin Resistance • Condition of low insulin sensitivity

  8. Glucose Metabolism

  9. Lipoprotein Metabolism

  10. Ketone Metabolism

  11. Protein Metabolism

  12. Insulin Amylin 600 400 200 0 Insulin and Amylin Co-secreted • Meal • Meal • Meal 30 25 Plasma amylin (pM) Without Diabetes n = 6 Plasma insulin (pM) 20 15 10 5 7 am 12 noon 5 pm Midnight Time Koda et al, Diabetes. 1995; 44 (s1): 23BA. Data on file. (Fineman)

  13. Amylin • Secreted by pancreatic beta-cells • An anorectic hormone • Works on the brain to stimulate the feeling of satiety. • This results in decreased G.I. motility, slowed carbohydrate absorption, and decreased appetite.

  14. GLP-1 • “Incretin” hormone secreted by jejunal and ileal L cells in response to a meal • Stimulates insulin secretion • Decreases glucagon secretion • Slows gastric emptying • Reduces fuel intake (increases satiety) • Improves insulin sensitivity • Increases b-cell mass and improves b-cell function (animal studies)

  15. GLP-1 release following meal:comparison of control, T2DM & IGT

  16. Diabetes Pathophysiology

  17. Diabetes is a Multi-Hormonal Disease • Pancreatic hormones • Insulin (b-cell) • Glucagon (a-cell) • Amylin (b-cell) • Intestinal Hormones (Incretins) • GLP-1 (L-cells) • GIP (K-cells)

  18. Type 1 Diabetes: Pathophysiology • Impaired insulin secretion • Absolute insulin deficiency

  19. T1DM • Typically autoimmune (~90%) • Beta-cells destroyed by multiple antibodies. • Can occur at any age (but more in kids) • Fast progression (the older the slower) • Related to ketones @ • Urine ketones • Ketoacidosis • Weight loss, N&V, lethargy

  20. Ketogenesis • Normal physiological responses to carbohydrate shortages cause the liver to increase the production of ketone bodies from the acetyl-CoA generated from fatty acid oxidation. • Allows the heart and skeletal muscles primarily to use ketone bodies for energy, thereby preserving the limited glucose for use by the brain

  21. Honeymooning The ability of the failing b-cells to become hyper-productive and compensate for failing insulin response.

  22. T2DMDiagnosis characteristics • Insidious • Obesity (almost always), or weight gain • Related to other IRS signs • Hyperlipidemia, acanthosis nigricans • Older (↑Obesity = ↓Age; fatter = younger) • Ethnic links • Family history of T2DM • No ketones

  23. Acanthosis Nigricans Hyperpigmented, velvety patches of skin in axillary regions and neck (typically).

  24. Type 2 Diabetes: Pathophysiology • Impaired insulin secretion • Absolute or relative insulin deficiency • Impaired insulin action (sensitivity) • Insulin resistance

  25. Dual Metabolic Abnormalities in Type 2 Diabetes Insulin Resistance Insulin Deficiency Decreased Glucose Uptake Decreased Insulin Secretion Unrestrained Lipolysis Excessive Hepatic Glucose Output

  26. Natural History of T2DM Symptomatic Obesity IGT* Diabetes Hyperglycemia Post-meal Glucose Plasma Glucose Fasting Glucose 120 (mg/dL) Insulin Resistance Relative -Cell Function Diabetes 100 (%) -20 -10 0 10 20 30 Years of Diabetes *IGT = impaired glucose tolerance

  27. Insulin Resistance Syndrome (Metabolic Syndrome) Glucose Intolerance Dyslipidemia (High TG, Low HDL) Hypertension InsulinResistance PCOS Cardiovascular Disease Obesity

  28. C Response to Insulin Resistance:The Pancreatic b Cell (early T2DM) Genes Environment INSULIN RESISTANCE Normal b cells Abnormal b cells Hyperinsulinemia (normal glucose) Hyperglycemia (relative insulin deficiency)

  29. Hepatic Insulin Resistance(T2DM) 25 20 15 10 5 0 Glycogenolysis Hepatic glucose output (µmol/kg/min) Gluconeogenesis CON T2DM Adapted from Consoli A. Diabetes 1989;38:550–557.

  30. Relative Organ Contribution to Decreased Glucose Uptake 7 6 5 4 3 2 1 0 Splachnic Adipose Insulin-stimulated Glucose Uptake (mg/kg/min) Muscle Brain Control T2DM Adapted from DeFronzo RA. Diabetes 1988;37:667–687.

  31. C Insulin Resistance:Inherited and Acquired Influences Inherited Acquired Rare Mutations l Insulin receptorl Glucose transporterl Signalling proteins Common Forms l Largely unidentified l Inactivity l Obesity l Stress l Medications l Glucose toxicity l Lipotoxicity INSULIN RESISTANCE

  32. Atypical diabetes

  33. Idiopathic type 1 diabetes • Also known as “Flatbush diabetes” • African American and Asian men (18-25) • Fluctuating insulin secretion • No antibodies • Many honeymoons

  34. LADA • Latent autoimmune diabetes of adulthood • Like type 1 but diagnosed after age 25. • ~20% of those with diagnosis of T2 may actually have LADA. • Slower onset than type 1 dm. • Positive antibodies. • Low or no c-peptide • No family history

  35. MODY • Maturity Onset Diabetes of the Young • A collection of many (at least 6) inherited diseases affecting insulin secretion. • Dominant inheritance characteristics • Normal insulin sensitivity • Impaired insulin secretion (but still some). • Diagnosis confirmed by genetic testing.

  36. Pancreatic Diabetes • Results from a failure of the pancreas as a whole. • May be secondary to ETOH abuse, trauma, repeat pancreatitis. • Exocrine pancreas generally fails before endocrine pancreas. • Will need pancreatic enzyme replacement as well as insulin.

  37. Gestational diabetes • Any glucose intolerance first diagnosed during pregnancy • Some definitions require return to normal following end of pregnancy. • Closely related to T2DM • Treat only with insulin • Some data support the use of SUs & metformin.

  38. Diagnosis of GDM with a 100-g oral glucose load

  39. A1C monitoring

  40. For every 1% point of increase in A1c add 35mg/dl of glucose.

  41. Elevated Iron deficiency anemia Splenectomy Decreased Hemolytic anemia Sickle cell anemia Transfusion False A1C Readings

  42. ADA Guidelines http://www.diabetes.org/

  43. Case #1

More Related